Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic".
Saved in:
| Title: | Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic". |
|---|---|
| Authors: | Shakshouk H; Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Dermatology, Andrology and Venereology, Alexandria University, Egypt., Daneshpazhooh M; Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Iran., Murrell DF; Department of Dermatology, University of New South Wales, Sydney, Australia., Lehman JS; Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Electronic address: lehman.julia@mayo.edu. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Jan; Vol. 84 (1), pp. e61-e62. Date of Electronic Publication: 2020 Sep 04. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
